CD56 marks an effector T cell subset in the human intestine

被引:26
|
作者
Cohavy, Offer [1 ]
Targan, Stephan R. [1 ]
机构
[1] Cedars Sinai Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 09期
关键词
D O I
10.4049/jimmunol.178.9.5524
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells are key mediators of intestinal immunity, and specific T cell subsets can have differing immunoregulatory roles in animal models of mucosal inflammation. In this study, we describe human CD56(+) T cells as a morphologically distinct population expressing a mature, nonproliferative phenotype that is frequent in the gut. Enhanced potential for IFN-gamma and TNF synthesis suggested a proinflammatory function, and we directly demonstrate effector function mediated by direct T-T interaction with responder cells in vitro. CD56(+) Ir cells from peripheral blood responded to the gut-related CD2 signal, and were necessary for effective CD2-mediated proliferation of peripheral blood CD56(-) T cells. Our findings associate CD56(+) T cells with the intestinal immune compartment and suggest a putative effector function in human mucosal immunity.
引用
收藏
页码:5524 / 5532
页数:9
相关论文
共 50 条
  • [21] CD56 is a functional immune receptor for aging T cells
    Montag, D. T.
    Lemster, B. H.
    Michel, J. J.
    Koeske, Z.
    Studenski, S. A.
    Vallejo, A. N.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S159 - S159
  • [22] Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
    Urban, Elizabeth M.
    Li, Haishan
    Armstrong, Cheryl
    Focaccetti, Chiara
    Cairo, Cristiana
    Pauza, C. David
    BMC IMMUNOLOGY, 2009, 10 : 50
  • [23] CD56 regulates human NK cell cytotoxicity through Pyk2
    Gunesch, Justin T.
    Dixon, Amera L.
    Ebrahim, Tasneem A. M.
    Berrien-Elliott, Melissa M.
    Tatineni, Swetha
    Kumar, Tejas
    Hegewisch-Solloa, Everardo
    Fehniger, Todd A.
    Mace, Emily M.
    ELIFE, 2020, 9 : 1 - 28
  • [24] Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
    Elizabeth M Urban
    Haishan Li
    Cheryl Armstrong
    Chiara Focaccetti
    Cristiana Cairo
    C David Pauza
    BMC Immunology, 10
  • [25] Defining the role of CD56/NCAM in human natural killer cell polarization and migration
    Martinez, A. L.
    Shannon, M. J.
    Mace, E. M.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 1155 - 1155
  • [26] CD5(-) CD56(+) T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
    Emile, JF
    Boulland, ML
    Haioun, C
    Kanavaros, P
    Petrella, T
    DelfauLarue, MH
    Bensussan, A
    Farcet, JP
    Gaulard, P
    BLOOD, 1996, 87 (04) : 1466 - 1473
  • [27] Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
    Blatner, Nichole R.
    Mulcahy, Mary F.
    Dennis, Kristen L.
    Scholtens, Denise
    Bentrem, David J.
    Phillips, Joseph D.
    Ham, Soo
    Sandall, Barry P.
    Khan, Mohammad W.
    Mahvi, David M.
    Halverson, Amy L.
    Stryker, Steven J.
    Boller, Anne-Marie
    Singal, Ashima
    Sneed, Rebekka K.
    Sarraj, Bara
    Ansari, Mohammed Javeed
    Oft, Martin
    Iwakura, Yoichiro
    Zhou, Liang
    Bonertz, Andreas
    Beckhove, Philipp
    Gounari, Fotini
    Khazaie, Khashayarsha
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (164)
  • [28] CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway
    Chen, Luxi
    Youssef, Youssef
    Robinson, Cameron
    Ernst, Gabrielle F.
    Carson, Mary Y.
    Young, Karen A.
    Scoville, Steven D.
    Zhang, Xiaoli
    Harris, Regine
    Sekhri, Palak
    Mansour, Anthony G.
    Chan, Wing K.
    Nalin, Ansel P.
    Mao, Hsiaoyin C.
    Hughes, Tiffany
    Mace, Emily M.
    Pan, Yinghong
    Rustagi, Navin
    Chatterjee, Sujash S.
    Gunaratne, Preethi H.
    Behbehani, Gregory K.
    Mundy-Bosse, Bethany L.
    Caligiuri, Michael A.
    Freud, Aharon G.
    IMMUNITY, 2018, 49 (03) : 464 - +
  • [29] The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
    C Pellat-Deceunynck
    S Barillé
    G Jego
    D Puthier
    N Robillard
    D Pineau
    M-J Rapp
    J-L Harousseau
    M Amiot
    R Bataille
    Leukemia, 1998, 12 : 1977 - 1982
  • [30] The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
    Pellat-Deceunynck, C
    Barillé, S
    Jego, G
    Puthier, D
    Robillard, N
    Pineau, D
    Rapp, MJ
    Harousseau, JL
    Amiot, M
    Bataille, R
    LEUKEMIA, 1998, 12 (12) : 1977 - 1982